Faire avancer la sûreté nucléaire

La Recherchev2


The scientific background to decorporation



Email :

Mot de passe :

D.M. Taylor, G.N. Stradling and M-H. Hengé-Napoli Radiat. Prot. Dosim. 2000 87(1), pp 11-18

Type de document > *Article de revue

Mots clés > radiotoxicologie, actinides, césium, cobalt, décorporation

Unité de recherche > Laboratoire d'études appliquées de radiotoxicologie (LEAR)

Auteurs >

Date de publication > 01/01/2000


The scientific background to chelation therapy is reviewed. A review of the animal studies which have demonstrated that in animals treated with DTPA either a reduction in bone tumour incidence from internally deposited 239Pu and 241Am, or a significant increase in survival time may occur, suggests that it is reasonable to assume that could also occur in humans. The biokinetics and bioinorganic chemistry of cobalt, caesium, thorium, uranium, neptunium, plutonium and americium after their entry into the systemic circulation are reviewed briefly. These reviews discuss the general biokinetic behaviour of each element in adult humans with special reference to those aspects of their bioinorganic chemistry that either underlie existing approaches to decorporation therapy, or which might be exploitable for new types of treatment.